Publications by authors named "Hans-Jorgen Malling"

Claim this Profile
[
[Hymenoptera venom allergy].
Hans-Jørgen Malling, Kirsten Skamstrup Hansen, Susanne Halken, Anne Caroline Curtz, Johannes Schmid

Ugeskr Laeger· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ARIA-EAACI care pathways for allergen immunotherapy in respiratory allergy.
Jean Bousquet, Oliver Pfaar, Ioana Agache, Anna Bedbrook, Cezmi A Akdis, Hans-Jørgen Malling

Clin Transl Allergy· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Anaphylaxis in children and adults].
Kirsten Skamstrup, Lene Heise Garvey, Carsten Bindslev-Jensen, Susanne Halken, Marianne Sjølin Frederiksen, Hans-Jørgen Malling

Ugeskr Laeger· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2019 ARIA Care pathways for allergen immunotherapy.
Jean Bousquet, Oliver Pfaar, Alkis Togias, Holger J Schünemann, Ignacio Ansotegui, Hans-Jørgen Malling

Allergy· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of immunotherapy with the recombinant B-cell epitope-based grass pollen vaccine BM32.
Verena Niederberger, Angela Neubauer, Philippe Gevaert, Mihaela Zidarn, Margitta Worm, Hans Jørgen Malling

J Allergy Clin Immunol· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proficiency testing of skin prick testers as part of a quality assurance system.
Hans-Jørgen Malling, Pernille Allesen-Holm, Lisbeth Sys Karved, Lars K Poulsen

Clin Transl Allergy· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prolonged efficacy of the 300IR 5-grass pollen tablet up to 2 years after treatment cessation, as measured by a recommended daily combined score.
Alain Didier, Hans-Jørgen Malling, Margitta Worm, Friedrich Horak, Gordon L Sussman

Clin Transl Allergy· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
"
"The value of pre- and co-seasonal sublingual immunotherapy in pollen-induced allergic rhinoconjunctivitis".
Pascal Demoly, Moises A Calderon, Thomas B Casale, Hans-Jørgen Malling, Ulrich Wahn

Clin Transl Allergy· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of a new communication template on anticipated willingness to initiate or resume allergen immunotherapy: an internet-based patient survey.
Moises A Calderon, Linda Cox, Thomas B Casale, Ralph Mösges, Oliver Pfaar, Hans-Jørgen Malling

Allergy Asthma Clin Immunol· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Anaphylaxis].
Hans-Jørgen Malling, Kirsten Skamstrup Hansen, Lene Heise

Ugeskr Laeger· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Anaphylaxis].
Hans-Jørgen Malling, Kirsten Skamstrup Hansen, Lene Heise Garvey

Ugeskr Laeger· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply: To PMID 24035151.
Hans-Jørgen Malling, Marianne Witten, Lars K Poulsen

J Allergy Clin Immunol· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sustained efficacy and safety of a 300IR daily dose of a sublingual solution of birch pollen allergen extract in adults with allergic rhinoconjunctivitis: results of a double-blind, placebo-controlled study.
Margitta Worm, Sabina Rak, Frédéric de Blay, Hans-Jorgen Malling, Michel Melac

Clin Transl Allergy· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is intralymphatic immunotherapy ready for clinical use in patients with grass pollen allergy?
Marianne Witten, Hans-Jørgen Malling, Lars Blom, Britta C Poulsen, Lars K Poulsen

J Allergy Clin Immunol· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Indication for adrenalin autoinjector after anaphylaxis].
Hans-Jørgen Malling, Kirsten Skamstrup Hansen, Holger Mosbech

Ugeskr Laeger· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allergen-specific immunotherapy with recombinant allergens.
G Pauli, Hans-Jørgen Malling

Curr Top Microbiol Immunol· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sensitization to cereals and peanut evidenced by skin prick test and specific IgE in food-tolerant, grass pollen allergic patients.
Maria Martens, Heidi J Schnoor, Hans-Jørgen Malling, Lars K Poulsen

Clin Transl Allergy· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sustained 3-year efficacy of pre- and coseasonal 5-grass-pollen sublingual immunotherapy tablets in patients with grass pollen-induced rhinoconjunctivitis.
Alain Didier, Margitta Worm, Friedrich Horak, Gordon Sussman, Olivier de Beaumont, Hans-Jorgen Malling

J Allergy Clin Immunol· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment with epinephrine (adrenaline) in suspected anaphylaxis during anesthesia in Denmark.
Lene H Garvey, Bo Belhage, Mogens Krøigaard, Bent Husum, Hans-Jørgen Malling

Anesthesiology· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[The influence of allergic rhinitis on asthma].
Ronald Dahl, Hans-Jørgen Malling, Lars Peter Nielsen, Nikolai Khaltaev, Jean Bousquet

Ugeskr Laeger· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subcutaneous immunotherapy for allergic rhinoconjunctivitis, allergic asthma, and prevention of allergic diseases.
Hans-Jørgen Malling, Jean Bousquet

Clin Allergy Immunol· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of recombinant birch pollen vaccine for the treatment of birch-allergic rhinoconjunctivitis.
Gabrielle Pauli, Tina H Larsen, Sabina Rak, Friedrich Horak, Elide Pastorello, Hans-Jorgen Malling

J Allergy Clin Immunol· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimal dose, efficacy, and safety of once-daily sublingual immunotherapy with a 5-grass pollen tablet for seasonal allergic rhinitis.
Alain Didier, Hans-Jörgen Malling, Margitta Worm, Friedrich Horak, Siegfried Jäger

J Allergy Clin Immunol· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality and clinical efficacy of allergen mixtures.
Hans-Jørgen Malling

Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Allergology in the regional Denmark. The Danish Society for Allergology].
Hans-Jørgen Malling,

Ugeskr Laeger· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis